Kaitlyn D’Onofrio

DocwireNews

Patients who underwent <a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/worse-than-death-hip-arthroplasty/">total hip arthroplasty</a> (THA) for <a href="https://www.docwirenews.com/abstracts/rheumatology-abstracts/prognostic-factors-for-progression-of-osteoarthritis-of-the-hip-a-systematic-review/">osteoarthritis</a> (OA) of the hip did not have a greater <a href="https://www.docwirenews.com/docwire-pick/are-you-heightened-risk-for-cancer/">risk for cancer</a> in a study published in the <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.32711">International Journal of Cancer</a>.&ldquo;Previous studies on the risk of cancer after total hip arthroplasty (THA) contradict each other, and many are hampered by small cohort sizes, residual confounding, short observation times, or a mix of indications underlying the THA procedure,&rdquo; the study authors reported. &ldquo;We evaluated the risk of cancer after total hip arthroplasty due to osteoarthritis in a nationwide cohort by comparing cancer incidences in individuals exposed to total hip arthroplasty due to osteoarthritis and in unexposed, sex&#8208;, age&#8208; and residence matched individuals.&rdquo;Researchers compared 126,276 patients who underwent a cemented THA between 1992 and 2012 to 555,757 patients who did not undergo surgery. For operative patients, follow-up began on the day of the index surgery; nonoperative patients matched to the THA cohort were given the same follow-up start day. Final follow-up day was the first to occur of day of death, emigration, or censuring, or Dec. 31, 2012. Data were collected from the Swedish Hip Arthroplasty Registry (SHAR), the Swedish Cancer Registry, the Swedish National Patient Registry and Statistics Sweden; collected information included procedural THA details, cancer diagnoses, comorbidities, and socioeconomic background. The main outcome was cancer occurrence after the first day of follow-up.Compared to the control group, THA patients had a slightly lower adjusted risk for cancer (hazard ratio [HR] 0.97; confidence interval [CI] 0.95-0.99). The operative cohort only had a significantly increased risk for one type of cancer&mdash;skin melanoma (HR 1.15; CI 1.05 &#8208; 1.24).&ldquo;We attained similar risk estimates in analyses stratified by sex, in individuals with minimum 5&thinsp;years of follow&#8208;up, in an analysis including individuals with a history of previous cancer, and in patients with cementless THA,&rdquo; the researchers added.The authors concluded that their findings could be part of &ldquo;reassuring&rdquo; information given to prospective THA patients prior to surgery.Mortality rates associated with falls are on the rise in older adults in the United States, <a href="https://www.reuters.com/article/us-health-elderly-falls/more-elderly-americans-dying-from-falls-idUSKCN1T5213">recent research</a> has found, making the findings even more critical. According to the&nbsp;<a href="https://www.cdc.gov/homeandrecreationalsafety/falls/adultfalls.html">Centers for Disease Control and Prevention</a>, more than one out of four adults aged 65 years and older falls every year&mdash;but most do not tell their doctor. And patients with a history of falls are significantly more likely to fall again. One in every five falls results in a serious injury, one of the most common being broken bones.

Jordana Jampel

Glycan-Targeting Novel Vaccine Shows Promise for Vast Virus Protection

Infectious Disease

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Latest News

THA Not Associated with Increased Cancer Risk

Oncology

Patients who underwent total hip arthroplasty (THA) for osteoarthritis (OA) of the hip did not have a greater risk for cancer in a study published in the International Journal ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe